DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
1-Year Return 0.48%
This Quarter Return
-19.51%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$201M
AUM Growth
-$42.4M
Cap. Flow
+$8.44M
Cap. Flow %
4.2%
Top 10 Hldgs %
47.8%
Holding
87
New
12
Increased
27
Reduced
14
Closed
4

Top Buys

1
IBB icon
iShares Biotechnology ETF
IBB
$3.74M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.85M
3
LOXO
Loxo Oncology, Inc
LOXO
$1.68M
4
VKTX icon
Viking Therapeutics
VKTX
$1.37M
5
CNCE
Concert Pharmaceuticals, Inc.
CNCE
$1.33M

Top Sells

1
BCRX icon
BioCryst Pharmaceuticals
BCRX
$1.51M
2
IMMU
Immunomedics Inc
IMMU
$1.37M
3
NVAX icon
Novavax
NVAX
$1.32M
4
KURA icon
Kura Oncology
KURA
$1.29M
5
IMDZ
Immune Design Corp.
IMDZ
$1.13M

Sector Composition

1 Healthcare 88.75%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARDX icon
51
Ardelyx
ARDX
$1.58B
$846K 0.42%
472,859
– –
MDGL icon
52
Madrigal Pharmaceuticals
MDGL
$9.61B
$744K 0.37%
+6,600
New +$744K
URGN icon
53
UroGen Pharma
URGN
$870M
$646K 0.32%
15,000
– –
SCYX icon
54
SCYNEXIS
SCYX
$36.4M
$613K 0.3%
127,293
– –
OBSV
55
DELISTED
ObsEva SA Ordinary Shares
OBSV
$561K 0.28%
44,338
+1,000
+2% +$12.7K
CDTX icon
56
Cidara Therapeutics
CDTX
$1.65B
$500K 0.25%
10,638
– –
SPRO icon
57
Spero Therapeutics
SPRO
$120M
$431K 0.21%
70,000
– –
VLRX
58
DELISTED
VALERITAS HOLDINGS INC
VLRX
$431K 0.21%
+66,250
New +$431K
ALDX icon
59
Aldeyra Therapeutics
ALDX
$332M
$415K 0.21%
+50,000
New +$415K
KALV icon
60
KalVista Pharmaceuticals
KALV
$765M
$399K 0.2%
20,225
+2,500
+14% +$49.3K
LRMR icon
61
Larimar Therapeutics
LRMR
$331M
$358K 0.18%
6,023
-1,131
-16% -$67.2K
LPTX icon
62
Leap Therapeutics
LPTX
$11.7M
$340K 0.17%
17,000
+2,936
+21% +$58.7K
RDUS
63
DELISTED
Radius Health, Inc.
RDUS
$338K 0.17%
20,500
– –
ARCT icon
64
Arcturus Therapeutics
ARCT
$455M
$330K 0.16%
+72,805
New +$330K
MASI icon
65
Masimo
MASI
$7.77B
$322K 0.16%
3,000
– –
ADXS
66
DELISTED
Advaxis, Inc.
ADXS
$317K 0.16%
111,111
– –
RIGL icon
67
Rigel Pharmaceuticals
RIGL
$720M
$316K 0.16%
13,760
– –
PHAS
68
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$309K 0.15%
+100,000
New +$309K
STRO icon
69
Sutro Biopharma
STRO
$86.5M
$284K 0.14%
31,494
+4,000
+15% +$36.1K
APTX
70
DELISTED
Aptinyx Inc. Common Stock
APTX
$240K 0.12%
14,500
– –
SLGL icon
71
Sol-Gel Technologies
SLGL
$78M
$211K 0.1%
3,500
– –
KA
72
DELISTED
Kineta, Inc. Common Stock
KA
$177K 0.09%
+390
New +$177K
NERV icon
73
Minerva Neurosciences
NERV
$16.2M
$176K 0.09%
3,261
-102
-3% -$5.51K
KDMN
74
DELISTED
Kadmon Holdings, Inc.
KDMN
$136K 0.07%
65,500
+2,500
+4% +$5.19K
LCTX icon
75
Lineage Cell Therapeutics
LCTX
$274M
$91K 0.05%
100,000
-14,300
-13% -$13K
1 2
3
4